Miras, Dionne Chixx .

HRN: 16-36-77  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/07/2022
12/14/2022
IV
240mg
Q8hours
Sepsis (Staphylococcus Epidermidis)
Waiting Final Action 

Indication:  Culture-directed    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: